As of Friday close, Colgate-Palmolive Company’s (NYSE:CL) stock was down -$0.75, moving down -1.03 percent to $72.20. The average number of shares traded per day over the past five days has been 6,080,740 shares. 2 times new highs have been achieved over the past 5 days, with a $0.89 gain in that time frame. In the last twenty days, the average volume was 4,281,195, while in the previous 50 days, it was 4,593,462.
Since last month, CL stock retreated -0.69%. Shares of the company fell to $70.92 on 03/09/23, the lowest level in the past month. A 52-week high of $83.81 was reached on 01/06/23 after having rallying from a 52-week low of $67.84. Since the beginning of this year, CL’s stock price has dropped by -8.36% or -$6.59, and marked a new high 3 times. However, the stock has declined by -13.85% since its 52-week high.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
CL stock investors should be aware that Colgate-Palmolive Company (CL) stock had its last reported insider trading activity 5 days ago on Mar 13. Kooyman John W, the Chief of Staff of the company, disposed of 2,040 shares for $71.67 on Mar 13. It resulted in a $146,209 divestment by the insider. CAHILL JOHN T sold 5,703 shares at an average price of $73.83 on Feb 27. The insider now owns 24,383 shares following the transaction. On Feb 27, Director POLK MICHAEL B sold 5,559 shares at $73.48 apiece. The transaction was valued at $408,494.
Right now, Colgate-Palmolive Company (CL) has a P/E ratio of about 33.99. The stock’s beta is 0.48. Besides these, the trailing price-to-sales (P/S) ratio of 3.34, the price-to-book (PB) ratio of 150.42, and the price-to-cash flow ratio of 354.90 may also be considered.
The latest dividend of $0.48 per share was paid out, which is 2.13% more than last year’s $0.47.
In the three months ended December 30, Colgate-Palmolive Company’s quick ratio stood at 0.80, while its current ratio was 1.30, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending December 30 was 21.80, and the total debt-to-equity ratio was 21.86. On the profitability front, the trailing twelve-month gross margin is 57.00% percent. In the year ended December 30, operating margins totaled 16.00%. Based on annual data, CL earned $10.25 billion in gross profit and brought in $17.97 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 24.00%. Return on equity (ROE) for the past 12 months was 472.20%.
In Colgate-Palmolive Company’s quarter-end financial report for December 30, it reported total debt of $8.74 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. CL’s revenue rose 4.88% to $4.46 billion during the quarter, while net income inched up to $4.63 billion. While analysts expected Colgate-Palmolive Company to report $0.76 quarterly earnings, the actual figure was $0.77 per share, beating the consensus estimate by 1.30%. During the quarter, the company generated $1.06 billion in EBITDA. The liabilities of Colgate-Palmolive Company were 14.93 billion at the end of its most recent quarter ended December 30, and its total debt was $8.77 billion. The value of shareholders’ equity is $830.38 million.
This quick technical analysis looks at Colgate-Palmolive Company’s (CL) price momentum. With a historical volatility rate of 16.79%, the RSI 9-day stood at 44.92% on 17 March.
With respect to its five-day moving average, the current Colgate-Palmolive Company price is up by +1.25% percent or $0.89. At present, CL shares trade -0.78% below its 20-day simple moving average and +1.02% percent above its 100-day simple moving average. However, the stock is currently trading approximately -9.34% below its SMA50 and -8.39% below its SMA200.
Stochastic coefficient K was 55.35% and Stochastic coefficient D was 48.54%, while ATR was 1.21. Given the Stochastic reading of 40.38% for the 14-day period, the RSI (14) reading has been calculated as 44.28%. As of today, the MACD Oscillator reading stands at 0.70, while the 14-day reading stands at 0.21.
Citigroup launched its rating on Colgate-Palmolive Company (NYSE: CL) to a Buy in a note to investors on February 17, 2023. Colgate-Palmolive Company (CL) has been rated Overweight by analysts. According to 0 brokerage firms, CL is a sell, and 13 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Colgate-Palmolive Company stock as buy, with 10 recommending it as overweight.
With a median target price of $82.00, the current consensus forecast for the stock is $67.00 – $90.00. Based on these forecasts, analysts predict Colgate-Palmolive Company (CL) will achieve an average price target of $81.17.